BidaskClub lowered shares of Surgery Partners (NASDAQ:SGRY) from a hold rating to a sell rating in a research report report published on Wednesday.

Several other brokerages also recently weighed in on SGRY. ValuEngine downgraded shares of Surgery Partners from a hold rating to a sell rating in a research note on Tuesday, May 22nd. Stifel Nicolaus raised shares of Surgery Partners from a sell rating to a hold rating and set a $15.00 price objective on the stock in a research report on Thursday, June 28th. Zacks Investment Research downgraded shares of Surgery Partners from a buy rating to a hold rating in a research report on Wednesday, August 29th. Leerink Swann initiated coverage on shares of Surgery Partners in a research report on Tuesday, August 7th. They issued an outperform rating and a $20.00 price objective on the stock. Finally, Royal Bank of Canada increased their price objective on shares of Surgery Partners from $18.00 to $20.00 and gave the company an outperform rating in a research report on Friday, August 10th. One analyst has rated the stock with a sell rating, four have issued a hold rating and five have issued a buy rating to the company’s stock. Surgery Partners presently has a consensus rating of Hold and a consensus price target of $19.43.

Shares of SGRY opened at $15.45 on Wednesday. Surgery Partners has a fifty-two week low of $7.10 and a fifty-two week high of $19.95. The company has a debt-to-equity ratio of 1.69, a quick ratio of 1.44 and a current ratio of 1.59.

Surgery Partners (NASDAQ:SGRY) last announced its earnings results on Thursday, August 9th. The company reported ($0.18) earnings per share for the quarter, topping the consensus estimate of ($0.25) by $0.07. Surgery Partners had a negative net margin of 5.56% and a negative return on equity of 1.67%. The firm had revenue of $444.78 million for the quarter, compared to the consensus estimate of $428.50 million. During the same period in the prior year, the firm earned ($0.09) EPS. The firm’s revenue for the quarter was up 54.2% on a year-over-year basis. analysts expect that Surgery Partners will post -0.49 earnings per share for the current fiscal year.

In other Surgery Partners news, insider Brandan Lingle sold 10,000 shares of the stock in a transaction that occurred on Tuesday, August 28th. The shares were sold at an average price of $18.15, for a total value of $181,500.00. Following the sale, the insider now directly owns 20,393 shares of the company’s stock, valued at approximately $370,132.95. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Corporate insiders own 8.20% of the company’s stock.

Large investors have recently made changes to their positions in the business. US Bancorp DE increased its position in shares of Surgery Partners by 76.6% in the 2nd quarter. US Bancorp DE now owns 7,328 shares of the company’s stock valued at $109,000 after purchasing an additional 3,179 shares during the last quarter. MetLife Investment Advisors LLC purchased a new stake in shares of Surgery Partners in the 1st quarter valued at approximately $164,000. Bank of Montreal Can acquired a new position in shares of Surgery Partners in the 2nd quarter valued at $149,000. Raymond James & Associates acquired a new position in shares of Surgery Partners in the 2nd quarter valued at $185,000. Finally, GSA Capital Partners LLP acquired a new position in shares of Surgery Partners in the 1st quarter valued at $222,000. 97.53% of the stock is currently owned by institutional investors.

About Surgery Partners

Surgery Partners, Inc, through its subsidiaries, operates surgical facilities in the United States. The company operates through three segments: Surgical Facility Services, Ancillary Services, and Optical Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management.

Further Reading: Fundamental Analysis and Individual Investors

Analyst Recommendations for Surgery Partners (NASDAQ:SGRY)

Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.